Table 1.

Benefits of early treatment of hemophilic patients with inhibitors

1. Earlier resolution of, and more rapid recovery from, bleeding episodes6

2. Improved efficacy at lower dose and lower cost4–6

3. Reductions in long-term arthropathy6

4. Reductions in hospitalizations and surgeries required6

5. Possibility of home treatment4